@article{cb50a0236e9742bf8696de2e78271ec6,
title = "Reply duration of triple therapy: A clinical question yet to be answered",
author = "Nikolaus Sarafoff and Byrne, \{Robert A.\} and Julinda Mehilli and Dirk Sibbing and Kristensen, \{Steen D.\} and Laugwitz, \{Karl Ludwig\} and Michael Maeng and Adnan Kastrati",
note = "Funding Information: Please note: Dr. Sarafoff has received fees for lectures or traveling from Lilly/Daiichi-Sankyo, Boehringer Ingelheim, AstraZeneca, Bayer Healthcare, Boston Scientific, Biotronik, and Medtronic. Dr. Byrne has received lecture fees from B. Braun and Biotronik; and has received fees for lectures, advisory board service, or traveling from Abbott Vascular and Medtronic. Dr. Mehilli has received fees for lectures and advisory board service from Abbot Vascular, Terumo, and Lilly/Daiichi-Sankyo. Dr. Sibbing has received speaker fees and honoraria for consulting from Eli Lilly, Daiichi-Sankyo, Bayer Vital, AstraZeneca, Verum Diagnostica, and Roche Diagnostics; and has received research grants from Roche Diagnostics. Dr. Kristensen has received lecture fees from AstraZeneca, Eli Lilly, Sanofi, and The Medicines Company. Dr. Kastrati has received payments for lectures or event adjudication activity from Abbott, AstraZeneca, Biosensors, Biotronik, Daiichi-Sankyo, MSD, and The Medicines Company; and holds patents related to stent technology. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. ",
year = "2015",
month = nov,
day = "17",
doi = "10.1016/j.jacc.2015.08.886",
language = "English",
volume = "66",
pages = "2266--2267",
journal = "Journal of the American College of Cardiology",
issn = "0735-1097",
publisher = "Elsevier Inc.",
number = "20",
}